US Stock MarketDetailed Quotes
ALLR Allarity Therapeutics
- 1.1000
- -0.0100-0.90%
Close Nov 29 13:00 ET
- 1.1100
- +0.0100+0.91%
Post 16:26 ET
4.88MMarket Cap-156P/E (TTM)
1.1400High1.0900Low119.20KVolume1.1400Open1.1100Pre Close131.65KTurnover2.69%Turnover Ratio0.00P/E (Static)4.43MShares666.000052wk High0.38P/B4.88MFloat Cap1.090052wk Low--Dividend TTM4.43MShs Float15288000.0000Historical High--Div YieldTTM4.51%Amplitude1.0900Historical Low1.1040Avg Price1Lot Size
Allarity Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -1.25%-5.44M | -189.10%-7.22M | 53.55%-1.49M | 24.21%-12.75M | 31.64%-1.67M | -21.96%-5.38M | 40.68%-2.5M | 44.38%-3.2M | -12.97%-16.82M | 43.37%-2.45M |
| Net income from continuing operations | -160.63%-11.59M | 31.55%-1.63M | -14.65%-3.84M | 25.89%-11.9M | 39.32%-1.72M | 11.71%-4.45M | 53.36%-2.38M | -8.83%-3.35M | 39.74%-16.06M | 83.12%-2.84M |
| Operating gains losses | -370.00%-47K | -12.08%-2.14M | -25.00%-495K | 68.20%-5.83M | -4.03%-3.51M | 97.14%-10K | -243.45%-1.91M | 97.18%-396K | -676.79%-18.34M | -1,830.29%-3.38M |
| Depreciation and amortization | -44.44%5K | -88.89%1K | -80.00%2K | -38.33%37K | 350.00%9K | -18.18%9K | -62.50%9K | -56.52%10K | -43.40%60K | -87.50%2K |
| Deferred tax | ---432K | --0 | ---14K | 106.02%97K | 135.93%97K | --0 | --0 | --0 | -8,160.00%-1.61M | -114.29%-270K |
| Other non cash items | -92.54%57K | -95.91%20K | 10.34%96K | 1,040.58%1.57M | 129.36%234K | 820.48%764K | -40.80%489K | 234.62%87K | -93.30%138K | -176.34%-797K |
| Change In working capital | -73.79%-3.16M | -419.48%-3.58M | 405.78%2.89M | 1,121.95%3.35M | 273.58%3.48M | -403.68%-1.82M | 70.32%1.12M | 122.71%571K | -105.89%-328K | -85.84%931K |
| -Change in receivables | -508.33%-73K | 66.44%-248K | -2,143.48%-516K | ---26K | -4.96%748K | 93.81%-12K | -435.51%-739K | 94.95%-23K | --0 | --787K |
| -Change in prepaid assets | 222.16%215K | -53.32%176K | 4,083.33%239K | 69.26%-190K | -231.90%-385K | -145.71%-176K | 10.88%377K | 99.51%-6K | -575.38%-618K | -243.21%-116K |
| -Change in payables and accrued expense | -52.43%-3.33M | -334.01%-3.48M | 389.00%3.07M | 51.84%2.23M | 31.44%2.3M | -647.37%-2.18M | 148.00%1.49M | 149.02%627K | -75.13%1.47M | -71.68%1.75M |
| -Change in other current assets | -94.42%31K | -200.00%-21K | 621.05%99K | 225.35%1.35M | 155.97%820K | 1,584.85%556K | 93.91%-7K | -104.04%-19K | -226.36%-1.08M | -528.76%-1.47M |
| -Change in other current liabilities | --0 | --0 | --0 | 91.92%-8K | --0 | --0 | --0 | 65.22%-8K | 20.16%-99K | 19.23%-21K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -1.25%-5.44M | -189.10%-7.22M | 53.55%-1.49M | 24.21%-12.75M | 31.64%-1.67M | -21.96%-5.38M | 40.68%-2.5M | 44.38%-3.2M | -12.97%-16.82M | 43.37%-2.45M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -21.29%791K | -460.00%-18K | |||||||
| Net PPE purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---18K | ---- |
| Net intangibles purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -19.50%809K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -21.29%791K | -460.00%-18K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -24.53%4.87M | 818.29%26.31M | 19.17%1.38M | 938.67%11M | -47.80%522K | 6.45M | 223.97%2.87M | 1.16M | -103.88%-1.31M | -94.58%1M |
| Net issuance payments of debt | --0 | 41.69%-1.34M | --1.34M | -364.90%-2.65M | -100.10%-1K | ---350K | ---2.3M | --0 | 3.20%1M | 732.91%1M |
| Net common stock issuance | -67.86%5.43M | --27.65M | --40K | --16.9M | --0 | --16.9M | --0 | --0 | --0 | --0 |
| Net preferred stock issuance | 95.24%-562K | --0 | --0 | -263.60%-5.49M | --0 | ---11.82M | 441.69%5.16M | --1.16M | ---1.51M | --0 |
| Proceeds from stock option exercised by employees | --0 | ---- | ---- | --2.24M | --523K | ---- | ---- | ---- | --0 | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 60.80%-800K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -24.53%4.87M | 818.29%26.31M | 19.17%1.38M | 938.67%11M | -47.80%522K | --6.45M | 223.97%2.87M | --1.16M | -103.88%-1.31M | -94.58%1M |
| Net cash flow | ||||||||||
| Beginning cash position | 4,479.29%19.23M | 5.76%312K | -91.82%166K | -89.62%2.03M | -64.55%1.4M | -94.53%420K | -97.97%295K | -89.62%2.03M | 6,462.08%19.56M | -29.33%3.95M |
| Current changes in cash | -153.54%-575K | 5,074.25%19.09M | 94.76%-107K | 89.91%-1.75M | 21.45%-1.15M | 124.36%1.07M | 105.66%369K | 58.69%-2.04M | -186.96%-17.34M | -110.37%-1.46M |
| Effect of exchange rate changes | -105.26%-195K | 29.51%-172K | -18.12%253K | 40.21%-113K | 81.68%-83K | -114.03%-95K | 29.89%-244K | 575.38%309K | 72.21%-189K | -198.03%-453K |
| End cash Position | 1,219.73%18.46M | 4,479.29%19.23M | 5.76%312K | -91.82%166K | -91.82%166K | -64.55%1.4M | -94.53%420K | -97.97%295K | -89.62%2.03M | -89.62%2.03M |
| Free cash flow | -1.25%-5.44M | -189.10%-7.22M | 53.55%-1.49M | 24.29%-12.75M | 32.14%-1.67M | -21.96%-5.38M | 40.68%-2.5M | 44.38%-3.2M | -13.09%-16.84M | 42.95%-2.46M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data